Product
ELVN-001
1 clinical trial
1 indication
Indication
Chronic Myeloid LeukemiaClinical trial
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2026-12-01
1 clinical trial
1 indication